Panel Discussion: Streamlining Regulatory Approaches to Optimize CDx Development, Reduce Complexities & Allow Patients Timely Access to Drug-Diagnostics Clinical Trials
Time: 9:30 am
day: Conference Day 2
Details:
- Given the fragmentation of regulatory requirements, will it be more beneficial to stakeholders to harmonise across APAC or will this create friction?
- Is there a future for there to be one solution that covers all regions to increase harmonisation and enable broader knowledge sharing between countries?
- Understanding different registration requirements across the region to increase commercialisation
- Aligning clinical practice with regulatory requirements: balancing the requirements of needing large panels in clinical trials to save the limited amount of tissue to get the maximum amount of information to make informed decisions vs the ease of getting a small focused panel approved
